Evidence map›Paper›PMID 32733936›Full record

ArticleBioMed research international2020

Triggering of Apoptosis in Osteosarcoma 143B Cell Line by Carbon Quantum Dots via the Mitochondrial Apoptotic Signal Pathway.

Yang Jiao, Yimin Guo, Yingcong Fan, Rui Wang, Xiang Li, Hao Wu, Zhichao Meng, Xin Yang, Yunpeng Cui, Heng Liu and 6 more

Abstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Heliyon · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yang JiaoDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Yimin GuoSchool of Materials Science and Engineering, Beihang University, Beijing 100191, China.
Yingcong FanPeking University Cancer Hospital & Institute, Beijing 100142, China.
Rui WangDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Xiang LiDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Hao WuDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Zhichao MengDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Xin YangDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Yunpeng CuiDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Heng LiuDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Liping PanDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Talatibaike MaimaitijumaDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.
Jiazhen ZhangSchool of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
Yahong WangHarbin Chengcheng Institute for Material and Life, Harbin 150500, China.
Yongping CaoDepartment of Orthopedic Surgery, Peking University First Hospital, Beijing 100034, China.ORCID https://orcid.org/0000-0003-0550-5991
Tao ZhangSchool of Materials Science and Engineering, Beihang University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-9561-3242

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCarbon-based nanomaterials have gained attention in the field of biomedicine in recent years, especially for the treatment of complicated diseases such as cancer. Here, we report a novel carbon-based nanomaterial, named carbon quantum dots (CQDs), which has potential for cancer therapy. We performed a systematic study on the effects of CQDs on the osteosarcoma 143B cell line in vitro and in vivo.

methodsCell counting assay, the neutral red assay, lactic dehydrogenase assay, and fluorescein isothiocyanate (FITC) Annexin V/Propidium iodide (PI) were used to detect the cytotoxicity and apoptosis of CQDs on the 143B cell line. Intracellular reactive oxygen species (ROS) were detected by the oxidation-sensitive fluorescent probe 2',7'-dichlorofluorescein diacetate. The JC-10 assay was used to detect the mitochondrial membrane potential (MMP) of 143B cells incubated with CQDs. The effects of CQDs on the 143B cell line were evaluated by Western blot and immunofluorescence analysis of apoptosis-related proteins Bax, Bcl-2, cytochrome-C, caspase-3, cleaved-caspase-3, PARP1, and cleaved-PARP1. Male tumor-bearing BALB/c nude mice were used to investigate the antitumor effects of CQDs, and the biosafety of CQDs in vivo was tested in male BALB/c mice by measuring weight changes, hematology tests, and histological analyses of major organs.

resultsCQDs exhibited a high cytotoxicity and induced apoptosis toward the 143B cell line. CQDs can also significantly increase the intracellular level of ROS and lower the mitochondrial membrane potential levels of 143B cells. CQDs increase apoptotic protein expression to induce apoptosis of 143B cells by triggering the mitochondrial apoptotic signaling pathway. The tumor volume in the CQD-treated mice was smaller than that in the control group, the tumor volume inhibition rate was 38.9%, and the inhibitory rate by tumor weight was 30.1%. All biosafety test indexes were within reference ranges, and neither necrosis nor inflammation was observed in major organs.

conclusionsCQDs induced cytotoxicity in the 143B cell line through the mitochondrial apoptotic signaling pathway. CQDs not only showed an antitumor effect but also high biocompatibility in vivo. As a new carbon-based nanomaterial, CQDs usage is a promising method for novel cancer treatments.

Indexed as

Signal TransductionAnimalsAntineoplastic AgentsApoptosisCarbonCell Line, TumorCell ProliferationHumansMaleMembrane Potential, MitochondrialMice, Inbred BALB CMice, NudeMitochondriaOsteosarcomaQuantum DotsReactive Oxygen SpeciesAntineoplastic AgentsCarbonReactive Oxygen Species

Identifiers

PMID32733936
PMCPMC7369657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.